Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
[ad_1] Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in
Read More
Eisai Co Ltd
What Eli Lilly investors can learn from the slow launch of a competitor's drug
[ad_1] Club holding Eli Lilly is expecting to get approval for its Alzheimer’s treatment in the coming weeks, but investors
Read More